Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 11/20 | 0.61 |
| ▸ | CA9 | Q16790 | 9/20 | 0.61 |
| ▸ | CA12 | O43570 | 8/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 9/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.47 |
| ▸ | CA1 | P00915 | 8/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9117013 | 0.86 | PTGS2 (0.56) | CA2CA9CA12PTGS2PTGS1 | |
| SCHEMBL9118655 | 0.86 | CA12 (0.55) | CA2CA9CA12PTGS2PTGS1 | |
| SCHEMBL9116322 | 0.86 | PTGS2 (0.64) | CA2CA9CA12PTGS2PTGS1 | |
| SCHEMBL9117156 | 0.86 | PTGS2 (0.46) | CA2CA9CA12PTGS2PTGS1 | |
| SCHEMBL9117510 | 0.83 | PTGS2 (0.64) | CA2CA9CA12PTGS2PTGS1 | |
| SCHEMBL9117882 | 0.83 | CA12 (0.55) | CA2CA9CA12PTGS2PTGS1 | |
| SCHEMBL9118542 | 0.82 | CA2 (0.58) | CA2CA9CA12PTGS2PTGS1 | |
| SCHEMBL9116120 | 0.82 | CA2 (0.58) | CA2CA9CA12PTGS2PTGS1 | |
| SCHEMBL9117564 | 0.82 | PTGS2 (0.59) | CA2CA9CA12PTGS2PTGS1 | |
| SCHEMBL9117753 | 0.82 | KIF11 (0.62) | CA2CA9CA12PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995030652-A1 | SUBSTITUTED SPIRODIENES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-11-16 | — | — | WO | disclosed |